The annual event brings together basic scientists, clinical researchers, early career investigators, clinicians and the care research community to discuss the latest developments and innovation in Alzheimer’s and dementia research.
With only a fifth of WHO Member States meeting their commitments to the Global Action Plan on dementia, urgent action is needed to address the escalating global dementia crisis.
The annual Alzheimer University (AU) assists emerging Alzheimer and dementia associations.
World Alzheimers Month 2021 has just ended and marks the most successful awareness raising campaign to date in its decade long history.
Eisai’s lecanemab will represent the second anti-Amyloid Beta therapy to be evaluated by the FDA as a disease modifying treatment for early Alzheimer’s disease.
This is the press release for the World Alzheimer Report 2021 'Journey through the diagnosis of dementia'
This report reviews progress towards the implementation of the 7 action areas of the plan by Member States, WHO and civil society, and all those involved in tackling the dementia pandemic.
People living with dementia and carers from all over the world have shared their experience of the journey to diagnosis for this year's World Alzheimer's Month campaign.
World Alzheimer’s Month is just around the corner and the STRiDE (Strengthening responses to dementia in developing countries) project teams have been busy planning activities to raise awareness and keep dementia on the policy agenda. The STRiDE project is led by the London School of Economics and Political Science, in…
Learn how you can support World Alzheimer's Month virtually this September.